Softwr

AI · head to head

LatchBio vs Manus

LatchBio logo

LatchBio

AI

AI agents that run bioinformatics analyses, from a company that pivoted from workflow hosting

From
On request
Rated
-
Manus logo

Manus

AI

General-purpose AI agent executing multi-step tasks in a hosted environment

From
On request
Rated
-

The short version

  • Each has a real cost: LatchBio the company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.; Manus specific pricing and plan tiers not published on accessible pages; users must visit pricing page or contact sales
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which LatchBio and Manus actually diverge.

Attributes where LatchBio and Manus differ
AttributeLatchBioManus
Pricing modelquotesubscription
PlatformsWebWeb, iOS, Android, Desktop, Slack integration

Identical on both: starting price (On request), free tier (No), user rating (Not yet rated), category (AI).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in LatchBio

  • Agent driven analysis
  • Multi assay support
  • Published benchmarks
  • White labelled portals
  • Common file format handling
  • Managed compute

Only in Manus

Nothing recorded that LatchBio does not also cover.

What people use each for

The jobs each tool is most often brought in to do.

LatchBio

  • A small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quicklynot Manus
  • An assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw filesnot Manus
  • A wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facilitynot Manus
  • A research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegatednot Manus

Manus

  • Autonomous research and report generationnot LatchBio
  • Slide deck and presentation creation from requirementsnot LatchBio
  • Website and graphic design automationnot LatchBio
  • Game development and interactive content creationnot LatchBio
  • Multi-step workflow automation via browser operatornot LatchBio

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

LatchBio

  • The company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.
  • Agent generated analysis code has to be validated by someone who could have written it, which inverts the value proposition for the small labs that most need it and cannot check the output.
  • No pricing is published, so the cost of routine agent analysis at team scale cannot be estimated without contacting sales, and compute billed through the platform makes the bill usage dependent.
  • Regulated use is a poor fit: an agent that writes non deterministic analysis code is difficult to validate under GxP, so this is a research tool rather than something that will sit in a regulated diagnostic or submission workflow.
  • The vendor publishes its own benchmarks, which is more than most competitors do, but self reported benchmarks on selected datasets are not a substitute for testing the agent on your own data before committing.

Manus

  • Specific pricing and plan tiers not published on accessible pages; users must visit pricing page or contact sales
  • Organisational transition mid-2026; unclear how this affects feature stability or pricing continuity
  • No clear free tier mentioned; access requires subscription from apparent launch
  • Limited public documentation on capabilities and limitations

Pricing, plan by plan

LatchBio

On request
  • LatchBio Platform$undefined/year
    • Quoted through a sales process
    • Interactive sandbox available for trying the agent before contracting
    • Enterprise and white labelled portal deployments priced separately

Manus

On request

No published plan breakdown. See the Manus review.

Which should you pick?

Choose LatchBio if

  • You need agent driven analysis.
  • You also want multi assay support.

Choose Manus if

  • You work on Web, iOS, Android, Desktop, Slack integration.

Questions people ask

Is LatchBio or Manus better?
Neither clearly leads. LatchBio starts at On request and Manus at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, LatchBio or Manus?
LatchBio starts at On request and Manus at On request.
Does LatchBio or Manus run on more platforms?
LatchBio runs on Web. Manus runs on Web, iOS, Android, Desktop, Slack integration.
What is LatchBio best used for?
LatchBio is most often used for a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly, an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files, a wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facility, a research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegated. Of those, a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly and an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files are not what Manus is typically brought in for.
What can LatchBio do that Manus cannot?
LatchBio covers Agent driven analysis, Multi assay support, Published benchmarks, White labelled portals.

Answered from the vendors’ own pages

LatchBio: Is LatchBio still selling the original workflow platform?

The company is now led by agent.bio and its agent products. Buyers evaluating the older Python SDK workflow platform should confirm current support directly.

Manus: Where can I find Manus pricing information?

The Manus pricing page at manus.im/pricing mentions 'Manus Pricing Plans' with the tagline 'Less structure, more intelligence,' but specific pricing details and tier information are not published online. Contact Manus directly to discuss pricing options.

Source
LatchBio: Can I try it before buying?

Yes. There is an interactive sandbox where you can upload data and run the agent before entering a sales conversation.

Manus: Does Manus offer a team plan option?

Manus mentions a team plan option on its pricing page, but specific details about team size limits, per-seat costs, and features are not published. Interested customers should contact Manus sales to discuss team pricing.

Source
LatchBio: Is it suitable for regulated work?

Not really. Non deterministic agent generated code is hard to validate under GxP, so treat it as a research and exploration tool.

Manus: What features are available in Manus?

Manus offers AI design, slides, image generation, music generation, browser operator, and other creative automation features. Specific feature availability by pricing tier requires contacting Manus directly for custom pricing information.

Source
LatchBio: What data types does it handle?

Single cell RNA sequencing, spatial transcriptomics, epigenomics, proteomics and pharmacology data, ingesting FastQ, H5AD and spreadsheet formats.

Share

Related pages

Other head to heads